Jindalee Resources Limited releases half-yearly financial report for the period ended on December 31st, 2022: Important facts and figures
Jindalee Resources Limited (ASX: JRL), (Jindalee, the Company), a mineral exploration company based in Western Australia, releases its...
VRX Silica Limited is all set for the Arrowsmith North Silica Sand Project: Signed Power LOI with ResourcesWA
VRX Silica Limited (ASX: VRX) (VRX or Company) has signed a Letter of Intent (LOI) with ResourcesWA, a company specialising in energy and...
Jindalee Resources’ McDermitt Lithium Project is Now the Largest Lithium Deposit in the United States
Jindalee Resources Limited (ASX: JRL) (Jindalee, or the Company) announces a significant update on its 100% owned US-based McDermitt...
Ajan Reginald: Biotech Entrepreneur
Roquefort Therapeutics (LSE: ROQ, QTCQB: ROQAF) (Roquefort) is an LSE main-market-listed BioTech company exploring the high-value and...
Roquefort Therapeutics PLC (LSE: ROQ) and Randox Laboratories Strike Exclusive License Agreement for Medical Diagnostics
Roquefort Therapeutics PLC (LSE: ROQ, OTCQB: ROQAF), a cancer-focused biotechnology company, has made a significant announcement recently....
An Exclusive Interview with Corey Nolan, Managing Director, Platina Resources Ltd
Platina Resources Ltd (ASX: PGM) is a gold-focused explorer with seven gold projects in Western Australia. Colitco is glad to have secured...
Platina Resources (ASX: PGM) Taps Into New Gold Resource Potential with Hermes Discovery
According to a recent ASX announcement, Platina Resources has successfully identified a new gold exploration target, Hermes, within the...
Platina Resources and Corey Nolan Reveal Striking Insights About Their Gold Projects
Figure 1: An Overview of the Company’s Gold-Focused Projects Platina Resources (ASX: PGM) is a leading gold exploration company based in...
Carbonxt Group Releases Its December 2022 Quarterly Report
Carbonxt Group LTD (ASX: CG1) (“Carbonxt” or the “Company”) has released its December 2022 quarterly report highlighting the key...
Roquefort Therapeutics Reports In-Vivo Safety for Midkine Oncology Antibodies
Roquefort Therapeutics (LSE: ROQ, OTCQB: ROQAF) (“Roquefort” or the “Company”) announces that two of its Midkine (MDK) antibody...
